Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Brain Communications|August 31, 2022
Brain atrophy in middle age using magnetic resonance imaging scans from Japan's health screening programmeSusumu Mori, Kengo Onda, Shohei Fujita, et al.
Melanoma Research|March 7, 2017
Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanomaKeitaro Fukuda, Takeru Funakoshi, Toshiharu Sakurai, et al.
Journal of Applied Clinical Medical Physics|February 14, 2015
Development of system using beam's eye view images to measure respiratory motion tracking errors in image-guided robotic radiosurgery systemMitsuhiro Inoue, Hiroya Shiomi, Hiromitsu Iwata, et al.
Japanese Journal of Radiology|August 2, 2019
Factors affecting the accuracy of respiratory tracking of the image-guided robotic radiosurgery systemMitsuhiro Inoue, Kohei Okawa, Junichi Taguchi, et al.
Oncology Letters|July 3, 2018
Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancerTatsuo Matsuda, Hiroya Takeuchi, Toshiharu Sakurai, et al.
Journal for Immunotherapy of Cancer|October 9, 2024
Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancerShigeo Koido, Junichi Taguchi, Masamori Shimabuku, et al.
Journal for Immunotherapy of Cancer|July 31, 2025
Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccineShigeo Koido, Junichi Taguchi, Masamori Shimabuku, et al.
Cancer Science|January 24, 2015
Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancerShuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, et al.
Nature Communications|March 12, 2024
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer modelsYouya Nakazawa, Masayuki Miyano, Shuntaro Tsukamoto, et al.
Endocrine Journal|April 7, 2022
Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profileAi Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, et al.
Pageof 3